Be The Match BioTherapies and NantKwest Announce Collaboration to Accelerate Development of Cell Therapy to Prevent COVID-19 Deaths May 19, 2020 08:00AM
NantKwest Names Sonja Nelson Chief Financial Officer Jun 19, 2018 05:00AM
NantKwest to Present at Jefferies 2018 Global Healthcare Conference Jun 5, 2018 01:29PM
NantWorks to Present Healthcare and Biotechnology Platforms at 36th Annual J.P. Morgan Healthcare Conference on January 9, 2018 in San Francisco, CA Jan 5, 2018 06:03PM
NantKwest (NK) Announces Publication of Preclinical Data of haNK Cell Therapy in Combination with Checkpoint Inhibitor Avelumab Jul 25, 2017 08:15AM


Jul 25, 2017 08:00AM NantKwest Announces Publication of Preclinical Data of haNK Cell Therapy in Combination with Checkpoint Inhibitor Avelumab Providing Strong Rationale for Advancement to Human Clinical Trials
Jun 6, 2017 08:00AM NantKwest Expands NANT Cancer Vaccine Program With Additional Clinical Trials Announced Addressing Multiple Cancer Types Across All Stages of Disease
May 18, 2017 08:00AM NantKwest Appoints Dr. John Lee as Senior Vice President of Adult Medical Affairs
May 16, 2017 08:00AM NantKwest Appoints Dr. Leonard Sender as Senior Vice President of Medical Affairs for Pediatric, Adolescent and Young Adult Oncology
May 9, 2017 07:21AM NantKwest (NK) and NantCell Announce FDA Authorization for NANT Cancer Vaccine Clinical Trials
May 9, 2017 07:00AM NantKwest and NantCell Announce FDA Authorization for the NANT Cancer Vaccine Clinical Trials, the First Novel Combination of Innate and Adaptive Immunotherapy in Patients with Pancreatic Cancer
Apr 4, 2017 08:07AM NantKwest (NK), Viracta Therapeutics Announce Series B Financing and Immunotherapy Pact
Apr 4, 2017 08:00AM NantKwest and Viracta Therapeutics Announce Series B Financing and Immunotherapy Partnership
Apr 3, 2017 01:12PM Precision Biologics to Highlight Preclinical Data on NEO-201, a Neoantigen Targeting Antibody in Oral Presentation at the 110th Annual Meeting of the American Association of Clinical Research
Mar 20, 2017 07:11AM NantKwest (NK) Receives FDA Orphan Drug Designation for aNK Natural Killer Cell Therapy in Merkel Cell Carcinoma
Mar 20, 2017 07:00AM NantKwest Announces FDA Grant of Orphan Drug Designation for the Company’s aNK Natural Killer Cell Therapy in Merkel Cell Carcinoma
Jan 10, 2017 12:00PM Imerys Carbonates is recognized for its sustainability commitment
Oct 4, 2016 10:09AM NantKwest (NK), Altor BioScience Enter co-Development Agreement on IL-15, IL-2 Development
Oct 4, 2016 10:00AM Altor BioScience Corporation and NantKwest Inc. Announce Co-Development Agreement to Advance Innovative Natural Killer Cell Combination Immunotherapies for the Treatment of Cancer
May 17, 2016 08:08AM NantKwest (NK) Offers Update on Three Clinical Programs at BofA Conference
May 17, 2016 08:00AM NantKwest Provides Update on Clinical Programs at Bank of America Healthcare Conference Multiple Immunotherapy Combinations Announced as Part of Cancer Moonshot 2020 Initiative
Mar 22, 2016 08:00AM Cancer MoonShot 2020 Milestone: National MoonShot IRB Established with Schulman IRB to Provide Central Review Services for National Immunotherapy Coalition (NIC) Clinical Trials
Mar 14, 2016 05:41PM INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Claims against NantKwest, Inc., and Strongly Encourages Investors with Losses to Contact the Firm
Mar 11, 2016 02:45PM IMPORTANT SHAREHOLDER NOTICE: Goldberg Law PC Announces An Investigation of Claims against NantKwest, Inc. And Strongly Encourages Investors With losses To Contact The Firm
Feb 22, 2016 08:00AM Nant Leaders to Share Vision of Cancer MoonShot 2020 Program at Premier Oncology Event
Dec 22, 2015 08:00AM NantKwest to Host Investor Day on January 14, 2016
Dec 18, 2015 07:00AM NantKwest Added to Nasdaq Biotechnology Index
Dec 16, 2015 07:00AM Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance
Dec 9, 2015 08:00AM NantKwest Announces Presentation of Preclinical Data of HER2.taNK at the San Antonio Breast Cancer Symposium (SABCS)
Nov 17, 2015 06:00AM NantKwest Names Angela Wilson Chief Financial Officer
Nov 12, 2015 08:00AM NantKwest Announces $50 Million Stock Repurchase Program
Nov 2, 2015 05:03PM NantKwest Announces Presentations at Upcoming Investment Conference Meetings
Oct 28, 2015 10:59AM Notable Analyst Rating Changes 10/28: (TWTR) (AAPL) (MAS) Upgraded; (FIVE) (MRVL) (SBLK) Downgraded
Jul 28, 2015 06:00AM NantKwest Inc. (Nasdaq: NK) to Ring The Nasdaq Stock Market Closing Bell
Jul 28, 2015 06:00AM NantKwest Inc. (Nasdaq: NK) to Ring The Nasdaq Stock Market Closing Bell